Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4Probiotics and Fermented FoodsGut microbiota and healthGastrointestinal motility and disorders

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 29 of the 53 sources its claims cite were checked for support.

Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis

Open access

Abstract

Recent research has highlighted the gut-brain axis as a critical modulator of mental health, positioning probiotics as promising psychobiotic interventions for anxiety, stress, depression, and cognitive function. Clinical trials investigating strains such as Lactobacillus rhamnosus, Bifidobacterium longum, Lactobacillus gasseri , and multi-strain formulations have demonstrated strain- and context-specific effects on psychological and physiological outcomes. While some studies reported improvements in mood, anxiety, sleep quality, and cognitive performance, others showed limited effects, particularly in healthy populations with low baseline stress levels, reflecting the challenges of translating preclinical findings into clinical applications in humans. Mechanistic evidence suggests that psychobiotics may influence neuroactive metabolites, short-chain fatty acids, γ -aminobutyric acid, serotonin, and anti-inflammatory pathways, thereby modulating cognitive and emotional processes. The effects happen dependent on factors such as dosage, strain specificity, delivery method, baseline stress or symptom levels, and co-administration with conventional treatments. Collectively, these findings underscore the potential of targeted psychobiotics to enhance mental well-being and support stress resilience, while highlighting the need for carefully designed clinical trials to clarify efficacy and mechanisms.

Overview

CoChat Summary

## TL;DR

This structured narrative review synthesizes human clinical trials of psychobiotics and finds that benefits are usually strain-specific, dose-dependent, and more evident in people with higher baseline stress or mood vulnerability. The paper concludes that psychobiotics can affect anxiety, stress, sleep, cognition, and related physiology through the gut-brain axis, but effects are inconsistent in healthy or low-stress populations.

## Key findings

  • In an RPCT of 86 healthy college students over 28 days, a multi-strain psychobiotic improved panic and neurophysiological anxiety, negative affect, worry, and negative mood regulation; post hoc analyses suggested CFU level mattered more than species count.
  • In an RDBPCOT of 29 healthy male participants, Lactobacillus rhamnosus JB-1 showed no significant effects on mood, anxiety, sleep quality, cognition, inflammatory markers, or HPA stress response versus placebo.
  • In a study of 71 participants with mild to severe depression over 8 weeks, Ecologic® BARRIER produced a significantly greater reduction in cognitive reactivity, especially in those with mild to moderate depression; the paper notes high attrition.
  • Across trials, reported effects included improvements in sleep quality and duration, cortisol, sIgA/IL-10, processing speed, hyperactivity, and depressive cognitive patterns, but the paper emphasizes that outcomes were strain-specific, domain-specific, and population-dependent.

## Methods

  • The paper is a structured narrative review of human clinical trials on psychobiotics and mental health via the gut-brain axis.
  • It searched Scopus, ScienceDirect, Nature, PubMed, Google Scholar, and ClinicalTrials.gov for studies from 2016 to 2025, using keywords including psychobiotics, probiotics, gut-brain axis, mental health, clinical trials, depression, anxiety, and human studies.
  • Included studies were peer-reviewed English-language human clinical trials assessing mental health outcomes and gut-brain-axis mechanisms; animal, in vitro, review, editorial, commentary, and conference abstract papers were excluded.

## Limitations

  • The paper states that, because this is a narrative review, database retrieval numbers were not prospectively recorded and no PRISMA flow diagram is provided.
  • The paper itself notes that the reviewed trials often had small samples, short intervention durations, high attrition in some studies, and mixed or null findings in healthy/low-stress populations.
  • Evident from the text: the review is not a meta-analysis and does not report pooled effect sizes; its conclusions therefore depend on the heterogeneous trial reports it summarizes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fmicb.2026.1804560

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical abstract Psychobiotics regulate the gut–brain axis through microbial metabolites and anti-inflammatory effects, improving gut health and contributing to reduced anxiety, better sleep, and enhanced mental well-being.
Graphical abstract Psychobiotics regulate the gut–brain axis through microbial metabolites and anti-inflammatory effects, improving gut health and contributing to reduced anxiety, better sleep, and enhanced mental well-being.CC BY · PubMed Central
Figure 1 Psychobiotics influence mental health through coordinated neural, immune, endocrine, and metabolic pathways. Specific Lactobacillus and Bifidobacterium strains modulate gut microbial composition, enhance production of neuroactive metabolites (e.g., GABA, serotonin precursors, short-chain fatty acids, indole derivatives), improve intestinal barrier integrity, and reduce systemic inflammation. These signals are transmitted to the central nervous system via the vagus nerve, hypothalamic–pituitary–adrenal (HPA) axis, and circulating microbial metabolites, ultimately affecting brain regions involved in emotional regulation, stress response, sleep, and cognition. The magnitude of psychobiotic effects is influenced by strain specificity, dosage, baseline psychological state, and lifestyle context. LPS, Lipopolysaccharides; IL-10, Interleukin-10; ENS, Enteric nervous system; GABA, γ-aminobutyric acid; SCFAs, Short-chain fatty acids.
Figure 1 Psychobiotics influence mental health through coordinated neural, immune, endocrine, and metabolic pathways. Specific Lactobacillus and Bifidobacterium strains modulate gut microbial composition, enhance production of neuroactive metabolites (e.g., GABA, serotonin precursors, short-chain fatty acids, indole derivatives), improve intestinal barrier integrity, and reduce systemic inflammation. These signals are transmitted to the central nervous system via the vagus nerve, hypothalamic–pituitary–adrenal (HPA) axis, and circulating microbial metabolites, ultimately affecting brain regions involved in emotional regulation, stress response, sleep, and cognition. The magnitude of psychobiotic effects is influenced by strain specificity, dosage, baseline psychological state, and lifestyle context. LPS, Lipopolysaccharides; IL-10, Interleukin-10; ENS, Enteric nervous system; GABA, γ-aminobutyric acid; SCFAs, Short-chain fatty acids.CC BY · PubMed Central

Verification

Claims the paper makes

21 Valid · 7 Not valid · 34 Not checked · 61 Own results and interpretations

42 more claims · 4 with their cited sources checked

Create a free account to see all 123 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 10
  • It may state two separate claims as one. 71
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Citations

Cites

Show all 54 references

Cited by

See all 4

Metadata

Authors
Sisubalan, N., Kesika, P., Sivamaruthi, B. S., & Chaiyasut, C.
Affiliations
  • University of Madras (IN)
  • Chiang Mai University (TH)
Corresponding author
  • Sivamaruthi, Bhagavathi Sundaram
  • Chaiyasut, Chaiyavat
Venue
Frontiers in microbiology
Published
2026-03-27
Volume
17
Pages
1804560-1804560
ISSN
1664-302X (ISSN-L)
OpenAlex
W7141684657
Cited by
4
References
54
Citations by year
2026: 4
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Chiang Mai University
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
psychobiotics, gut-brain axis, probiotics, mental health, anxiety, depression, stress, cognitive function, Lactobacillus rhamnosus, Bifidobacterium longum, Lactobacillus gasseri, short-chain fatty acids, GABA, serotonin, neuroactive metabolites, anti-inflammatory pathways, sleep quality, strain specificity, stress resilience

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis. https://app.cochat.ai/papers/10.3389/fmicb.2026.1804560
The paper
Sisubalan, N., Kesika, P., Sivamaruthi, B. S., & Chaiyasut, C. (2026). Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2026.1804560

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.